Boiron (FRA:BON) Change In Inventory : €-0.8 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Boiron Change In Inventory?

Boiron's change in inventory for the quarter that ended in Dec. 2023 was €6.5 Mil. It means Boiron's inventory declined by €6.5 Mil from Jun. 2023 to Dec. 2023 .

Boiron's change in inventory for the fiscal year that ended in Dec. 2023 was €-0.8 Mil. It means Boiron's inventory increased by €0.8 Mil from Dec. 2022 to Dec. 2023 .

Boiron's Total Inventories for the quarter that ended in Dec. 2023 was €96.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Boiron's Days Inventory for the quarter that ended in Dec. 2023 was 260.43.

Inventory Turnover measures how fast the company turns over its inventory within a year. Boiron's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.70.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Boiron's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.40.

Boiron Change In Inventory Historical Data

The historical data trend for Boiron's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Change In Inventory Chart

Boiron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.85

-15.93

1.26

-9.80

-0.83

Boiron Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															2.35	-6.64	-3.17	-7.32	6.49

Boiron Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.8 Mil.

Boiron (FRA:BON) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Boiron's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	100.1725	/	70.197	*	365 / 2
	=	260.43

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Boiron's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	70.197	/	100.1725
	=	0.70

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Boiron's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	100.1725	/	253.363
	=	0.40

Boiron Change In Inventory Related Terms

Thank you for viewing the detailed overview of Boiron's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Boiron (FRA:BON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (FRA:BON) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

BOIRF:USA BOI:France BON:Germany

Address

2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510

Website

http://www.boiron.com

Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.